Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

Author:

Xu Shuo1,Gu Zhenbang2,Zhu Wengen2,Feng Shenghui3

Affiliation:

1. Department of Respiratory and Critical Care Medicine Ganzhou People's Hospital Ganzhou China

2. Department of Cardiology First Affiliated Hospital of Sun Yat‐Sen University Guangzhou China

3. Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Abstract

AbstractWe performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023. Two researchers participated in data collection independently. Risk ratios (RRs) from included studies with 95% confidence intervals (CIs) were pooled in the Review Manager version 5.40 software using a random‐effects model for analysis. A total of 11 studies (3 post hoc analyses of RCTs and 8 observational studies) with 18 602 participants were included in this meta‐analysis. After pooling all the data from eligible studies, our results indicated that COPD was associated with an increased risk of hospitalization (RR = 1.66, 95% CI, 1.47–1.87, P < 0.00001), mortality (RR = 1.62, 95% CI, 1.34–1.95, P < 0.00001), and the composition of hospitalization or mortality (RR = 1.84, 95% CI, 1.35–2.51, P < 0.001) in patients with HFpEF. In a subgroup analysis, the risks of cardiovascular‐related mortality (RR = 1.59, 95% CI, 1.30–1.93, P < 0.00001) and post‐discharge mortality risk (RR = 2.57, 1.34–4.93, P < 0.01) were increased in HFpEF patients comorbid with COPD, and these associations were also detected in HF‐caused hospitalization (RR = 1.64, 95% CI, 1.44–1.87, P < 0.00001). Evidence from existing studies supported that COPD was an independent prognostic risk factor for patients with HFpEF. Developing rapid clinical diagnostic indicators and early use of novel drugs such as SGLT‐2 and ARNI may improve the prognosis of this population, deserving further study.

Publisher

Wiley

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3